The role of dimerization in prion replication

Biophysical Journal

Volumn 82, Issue 4, 2002, Pages 1711-1718

  Tompa, Peter ^a   Tusnády, Gábor E ^a   Friedrich, Peter ^a   Simon, István ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b INSTITUTE OF ENZYMOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CELL PROTEIN; DISULFIDE;

ARTICLE; CATALYSIS; DIMERIZATION; GENE REPLICATION; MOLECULAR MODEL; OXIDATION REDUCTION REACTION; POLYMERIZATION; PRION; PRION DISEASE;

EID: 0036215455     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(02)75523-9     Document Type: Article

References (69)

1. Prion research: The next frontiers
2. Prion protein structure and scrapie replication: Theoretical, spectroscopic, and genetic investigations
3. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da
4. A 54-kDa normal cellular protein may be the precursor of the scrapie agent protease-resistant protein
5. 3D domain swapping: A mechanism for oligomer assembly
6. Copurification of Sp33-37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease
7. Evidence for synthesis of scrapie prion proteins in the endocytic pathway
8. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae
9. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies
10. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease
11. Pathologic conformations of prion proteins
12. The scrapie replication-site hypothesis and its implications in the nervous system
13. Protein misfolding, evolution and disease
14. Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia
15. Thiol-disulfide interchange a potential key to conformational change associated with amyloid fibril formation
16. Different sequence environments of cysteines and half cystines in proteins. Application to predict disulfide forming residues
17. Predicting the oxidation state of cysteines by multiple sequence alignment
18. Properties of scrapie prion protein liposomes
19. Purified prion proteins and scrapie infectivity copartition into liposomes
20. Thermodynamics of model prions and its implications for the problem of prion protein folding
21. The importance of the disulfide bond in prion protein conversion
22. The nature of the scrapie agent: The evolution of the virino
23. Prion protein interconversions and the transmissible spongiform encephalopathies
24. Structural mobility of the human prion protein probed by backbone hydrogen exchange
25. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention
26. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations
27. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
28. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping
29. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation
30. Crystal structure of the human prion protein reveals a mechanism for oligomerization
31. Cell-free formation of protease-resistant prion protein
32. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein
33. NMR structure of the bovine prion protein
34. The role of disulfide bridge in the folding and stability of the recombinant human prion protein
35. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis
36. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein
37. A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP
38. On the nature of allosteric transitions: A plausible model
39. Recombinant scrapie-like prion protein of 106 amino acids is soluble
40. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
41. Equilibrium folding properties of the yeast prion protein determinant Ure2
42. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP
43. Prions
44. Attempts to restore scrapie prion infectivity after exposure to protein denaturants
45. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
46. Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form
47. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231)
48. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein τ controls the in vitro assembly of paired helical filaments
49. Physical properties of the Creutzfeldt-Jakob disease agent
50. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing
51. Familial mutations and the thermodynamic stability of the recombinant human prion protein
52. Synthesis and trafficking of prion proteins in cultured cells
53. Misfolding the way to disease
54. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
55. Prion proteins as memory molecules: An hypothesis
56. Prion protein: Evolution caught en route
57. A yeast prion provides a mechanism for genetic variation and phenotypic diversity
58. Purification and properties of the cellular and scrapie hamster prion proteins
59. Species barriers in a model for specific prion protein dimerisation
60. Modeling a prion protein dimer: Predictions for fibril formation
61. A model for prion protein dimerisation based on α-helical packing
62. The ninth datta lecture. Molecular biology of transmissible spongiform encephalopathies
63. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies
64. A role for intermolecular disulfide bonds in prion diseases?
65. Prions of yeast and fungi. Proteins as genetic material
66. Separation of scrapie prion infectivity from PrP amyloid polymers
67. Subcellular trafficking abnormalities of a prion protein with a disrupted disulfide loop
68. NMR solution structure of the human prion protein
69. Physical studies of conformational plasticity in a recombinant prion protein